Skip to Content

BNP (Canada)

This page contains information on BNP for veterinary use.
The information provided typically includes the following:
  • BNP Indications
  • Warnings and cautions for BNP
  • Direction and dosage information for BNP

BNP

This treatment applies to the following species:
Manufacturer: Vetoquinol

Neomycin and Polymyxin B Sulfates and Bacitracin Ophthalmic Ointment, USP

Sterile

DIN 00516414

VETERINARY USE ONLY

Active Ingredients

per g

Bacitracin Zinc

400 IU

Neomycin Sulfate (Equivalent to 3.4 mg of neomycin base)

5 mg

Polymyxin B Sulfate

5 000 IU

ACTIONS: The three antibiotics present in Bacitracin-Neomycin-Polymyxin ointment provide a broad spectrum of activity against the gram-positive and gram-negative bacteria commonly involved in superficial infections of the eyelid and conjunctiva. Polymyxin B is bactericidal to gram-negative bacteria especially Pseudomonas. No resistant strains have been found to develop in vivo. Bacitracin is effective against gram-positive bacteria including hemolytic and non-hemolytic streptococci and staphylococci. Resistant strains are rarely found. Neomycin is effective against gram-positive and gram-negative bacteria, including staphylococci, E. Coli and influenza and many strains of Proteus and Pseudomonas.

BNP Indications

In the treatment of superficial bacterial infection of the eyelid and conjunctiva in dogs and cats when due to organisms susceptible to the antibiotics contained in the ointment. Laboratory tests should be conducted including in vitro culturing and susceptibility tests on samples collected prior to treatment.

DOSAGE & ADMINISTRATION: Apply a thin film over the cornea three or four times daily. The area should be properly cleansed prior to the use of BNP ointment. Foreign bodies, crusted exudates, and debris should be carefully removed. Treatment can be continued for two days after the eye appears normal, or as recommended by a veterinarian.

CAUTIONS: Neomycin has been reported to cause allergic reactions in dogs and cats, particularly after prolonged usage. Neomycin containing products should be avoided in cats unless no other treatment options exist. If a reaction occurs, discontinue use of the preparation and treat symptomatically. As with any antibiotic preparation, prolonged use may result in overgrowth of non-susceptible organisms including fungi. Appropriate measures should be taken if this occurs. If infection does not respond to treatment in two or three days, the diagnosis and therapy should be reevaluated.

Care should be taken not to contaminate the applicator tip of the tube during application of the preparation. Do not allow the applicator tip to come in contact with any tissue.

Adverse Reactions

Itching, burning or inflammation may occur in animals sensitive to the product. Discontinue use in such cases.

Warnings

Keep out of reach of children.

STORAGE CONDITIONS: Store between 15°C and 25°C. Keep tightly closed.

Vetoquinol N.-A. Inc., 2000, ch. Georges, Lavaltrie (QC) Canada J5T 3S5

411550

Net

Code

 

3.5 g

992338

411530

312940

12 x 3.5 g

992339

411532

312940

CPN: 1234315.4

VETOQUINOL N.-A. INC.
Commercial Division

2000, CHEMIN GEORGES, LAVALTRIE, QC, J5T 3S5
Telephone:   450-586-2252
Order Desk:   800-363-1700
Fax:   450-586-4649
Website:   www.vetoquinol.ca
Email:   info@vetoquinol.ca
Every effort has been made to ensure the accuracy of the BNP information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide